Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat

Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat

Background and objectives: Access to safe and reliable contraception in the context of ARVs is essential. This study aimed to investigate the steady-state pharmacokinetics (PK) of ethinylestradiol/levonorgestrel (EE/LNG) 30/150 μg (Microgynon®) and atazanavir/cobicistat (ATV/COBI) 300/150 mg (Evotaz...

Full description

Bibliographic Details
Main Authors: Emilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, Saye Khoo, Nneka Nwokolo, Marta Boffito
Format: Article
Language:English
Published: Taylor & Francis Group 2019-05-01
Series:HIV Research & Clinical Practice
Subjects:
atazanavir
cobicistat
oral contraceptive
levonogestrel
ethinylestradiol
Online Access:http://dx.doi.org/10.1080/25787489.2019.1638077

Internet

http://dx.doi.org/10.1080/25787489.2019.1638077

Similar Items